- Home
- FDMT vs OVID Comparison
FDMT vs OVID Comparison
Compare FDMT & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | OVID |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6M | 522.6M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FDMT | OVID |
|---|---|---|
| Price | $9.42 | $2.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $31.71 | $4.60 |
| AVG Volume (30 Days) | 566.8K | ★ 1.8M |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | 3.90 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | $7,252,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.28 | $19.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 230194.60 | 1181.27 |
| 52 Week Low | $3.68 | $0.27 |
| 52 Week High | $12.34 | $3.11 |
Technical Indicators
Market Signals| Indicator | FDMT | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 47.66 |
| Support Level | $8.39 | $2.33 |
| Resistance Level | $9.78 | $2.72 |
| Average True Range (ATR) | 0.60 | 0.16 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 48.67 | 39.47 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.